Soleno Therapeutics, Inc. · NASDAQ:SLNO
T. Rowe Price Associates Inc's stake in Soleno Therapeutics, Inc. fell to 2.00% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Associates Inc's stake in Soleno Therapeutics, Inc. fell to 2.00%, 1,025,868 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 2.00%
- Shares
- 1,025,868
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Associates, Inc. | 2.00% | 1,025,868 |
Source
Related
- Soleno Therapeutics, Inc.
- T. Rowe Price Associates Inc
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2025
- Schedule 13G · T. Rowe Price Associates Inc · May 14, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026